JP2013531682A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013531682A5 JP2013531682A5 JP2013518868A JP2013518868A JP2013531682A5 JP 2013531682 A5 JP2013531682 A5 JP 2013531682A5 JP 2013518868 A JP2013518868 A JP 2013518868A JP 2013518868 A JP2013518868 A JP 2013518868A JP 2013531682 A5 JP2013531682 A5 JP 2013531682A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- revascularization
- subject
- anatomical
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000250 revascularization Effects 0.000 claims 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 230000002792 vascular Effects 0.000 claims 5
- 238000002399 angioplasty Methods 0.000 claims 3
- 210000001519 tissue Anatomy 0.000 claims 3
- 102000013566 Plasminogen Human genes 0.000 claims 2
- 108010051456 Plasminogen Proteins 0.000 claims 2
- 108010023197 Streptokinase Proteins 0.000 claims 2
- 210000005013 brain tissue Anatomy 0.000 claims 2
- 239000003527 fibrinolytic agent Substances 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 229960005202 streptokinase Drugs 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 238000007887 coronary angioplasty Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 229940012957 plasmin Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 210000005084 renal tissue Anatomy 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 108010073863 saruplase Proteins 0.000 claims 1
- 210000002027 skeletal muscle Anatomy 0.000 claims 1
- 229960000103 thrombolytic agent Drugs 0.000 claims 1
- 229960000187 tissue plasminogen activator Drugs 0.000 claims 1
- 229960005356 urokinase Drugs 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36313310P | 2010-07-09 | 2010-07-09 | |
| US36312910P | 2010-07-09 | 2010-07-09 | |
| US61/363,129 | 2010-07-09 | ||
| US61/363,133 | 2010-07-09 | ||
| US41265510P | 2010-11-11 | 2010-11-11 | |
| US61/412,655 | 2010-11-11 | ||
| PCT/US2011/043424 WO2012006569A1 (en) | 2010-07-09 | 2011-07-08 | Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016136149A Division JP2016172781A (ja) | 2010-07-09 | 2016-07-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013531682A JP2013531682A (ja) | 2013-08-08 |
| JP2013531682A5 true JP2013531682A5 (cg-RX-API-DMAC7.html) | 2014-08-21 |
| JP6319738B2 JP6319738B2 (ja) | 2018-05-09 |
Family
ID=45441572
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013518868A Active JP6319738B2 (ja) | 2010-07-09 | 2011-07-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2016136149A Pending JP2016172781A (ja) | 2010-07-09 | 2016-07-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2019000305A Pending JP2019052188A (ja) | 2010-07-09 | 2019-01-04 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2020080135A Pending JP2020114880A (ja) | 2010-07-09 | 2020-04-30 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2021181839A Pending JP2022012924A (ja) | 2010-07-09 | 2021-11-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016136149A Pending JP2016172781A (ja) | 2010-07-09 | 2016-07-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2019000305A Pending JP2019052188A (ja) | 2010-07-09 | 2019-01-04 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2020080135A Pending JP2020114880A (ja) | 2010-07-09 | 2020-04-30 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
| JP2021181839A Pending JP2022012924A (ja) | 2010-07-09 | 2021-11-08 | 虚血／再灌流障害に続くノーリフローの予防又は処置方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9345738B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP4285994A3 (cg-RX-API-DMAC7.html) |
| JP (5) | JP6319738B2 (cg-RX-API-DMAC7.html) |
| CN (4) | CN103249423A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2804404C (cg-RX-API-DMAC7.html) |
| HK (1) | HK1249428A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012006569A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2858550A1 (en) * | 2011-12-09 | 2013-06-13 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
| HK1204988A1 (en) * | 2012-02-22 | 2015-12-11 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating ophthalmic conditions |
| CA2869080C (en) * | 2012-03-30 | 2020-09-01 | Stealth Peptides International, Inc. | Methods and compositions for the prevention and treatment neuropathy |
| EP3586864A1 (en) * | 2013-05-14 | 2020-01-01 | Stealth Biotherapeutics Corp | Methods for the prevention or treatment of left ventricle remodeling |
| CA2916492A1 (en) | 2013-06-27 | 2014-12-31 | Stealth Biotherapeutics Corp | Peptide therapeutics and methods for using same |
| US11724030B2 (en) * | 2018-09-21 | 2023-08-15 | Corflow Therapeutics Ag | Method and apparatus for diagnosis and treatment of microvascular dysfunction |
| US10870678B2 (en) | 2016-04-11 | 2020-12-22 | Arcuate Therapeutics, Inc. | Chiral peptides |
| US11034724B2 (en) | 2017-04-05 | 2021-06-15 | Stealth Biotherapeutics Corp. | Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2 |
| AU2018336787B2 (en) | 2017-09-19 | 2024-05-30 | Corflow Therapeutics Ag | Intracoronary characterization of microvascular obstruction (MVO) and myocardial infarction |
| IL305687B2 (en) * | 2017-12-15 | 2024-12-01 | Stealth Biotherapeutics Inc | Mitochondria-targeting peptides |
| US11795196B2 (en) | 2017-12-15 | 2023-10-24 | Stealth Biotherapeutics Inc. | Mitochondria-targeting peptides |
| US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
| CN113544138B (zh) * | 2018-12-18 | 2024-10-29 | 隐形生物治疗公司 | 线粒体靶向肽 |
| WO2020131283A1 (en) * | 2018-12-18 | 2020-06-25 | Stealth Biotherapeutics Corp. | Analogs that target mitochondrial diseases |
| JPWO2020189593A1 (cg-RX-API-DMAC7.html) | 2019-03-20 | 2020-09-24 | ||
| RU2711414C1 (ru) * | 2019-03-27 | 2020-01-17 | Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) | Способ прогнозирования асимптомного повреждения вещества головного мозга при ангиореконструктивных операциях на сонных артериях |
| JP7638265B2 (ja) | 2019-07-24 | 2025-03-03 | ステルス バイオセラピューティクス インコーポレイテッド | 神経変性疾患の治療におけるペプチド模倣化合物（ｒ）－２－アミノ－ｎ－（（ｓ）－ｌ－（（（ｓ）－５－アミノ－ｌ－（３－ベンジル－１，２，４－オキサジアゾール－５－イル）ペンチル）アミノ）－３－（４－ヒドロキシ－２，６－ジメチルフェニル）－ｉ－オキソプロパン－２－イル）－５－グアニジノペンタンアミド |
| EP4792852A2 (en) | 2020-05-22 | 2026-08-19 | CorFlow Therapeutics AG | Controlled flow infusion microvascular dysfunction diagnostic and therapy |
| JP7533970B2 (ja) * | 2022-01-31 | 2024-08-14 | 株式会社ニューギン | 遊技機 |
| JP7478453B2 (ja) * | 2022-01-31 | 2024-05-07 | 株式会社ニューギン | 遊技機 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5182106A (en) * | 1986-05-15 | 1993-01-26 | Emory University | Method for treating hypothermia |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| JPH05301868A (ja) | 1992-04-23 | 1993-11-16 | Mitsui Toatsu Chem Inc | 虚血性心疾患治療剤 |
| US5674534A (en) | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| EP1526140B1 (en) * | 2002-08-01 | 2008-11-05 | Astellas Pharma Inc. | Potassium-dependent sodium-calcium exchanger |
| SI2656854T1 (sl) * | 2003-02-04 | 2015-09-30 | Cornell Research Foundation, Inc. | Uporabe aromatsko-kationskega peptida |
| CA3024434A1 (en) * | 2004-01-23 | 2005-08-11 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| EP3725324A1 (en) * | 2005-09-16 | 2020-10-21 | Cornell Research Foundation, Inc. | Aromatic-cationic peptide for use in a method for reducing cd36 expression |
| EP2519249A4 (en) * | 2009-12-31 | 2013-06-26 | Stealth Peptides Int Inc | METHOD FOR CARRYING OUT A CORONARY ARTERY BYPASS PROCEDURE |
| US20130195837A1 (en) * | 2009-12-31 | 2013-08-01 | Stealth Peptides International, Inc. | Methods for the prevention or treatment of vessel occlusion injury |
| EP2808029A3 (en) * | 2010-03-15 | 2015-04-01 | Stealth Peptides International, Inc. | Combination therapies using cyclosporine and aromatic cationic peptides |
-
2011
- 2011-07-08 CN CN2011800429365A patent/CN103249423A/zh active Pending
- 2011-07-08 CN CN201610616831.0A patent/CN106620645A/zh active Pending
- 2011-07-08 EP EP23185558.6A patent/EP4285994A3/en not_active Withdrawn
- 2011-07-08 JP JP2013518868A patent/JP6319738B2/ja active Active
- 2011-07-08 EP EP11804436.1A patent/EP2590664B1/en active Active
- 2011-07-08 US US13/808,027 patent/US9345738B2/en active Active
- 2011-07-08 EP EP19157391.4A patent/EP3539554A1/en not_active Withdrawn
- 2011-07-08 CA CA2804404A patent/CA2804404C/en active Active
- 2011-07-08 CN CN201710574500.XA patent/CN107569675A/zh active Pending
- 2011-07-08 CN CN201510122649.5A patent/CN105879008A/zh not_active Withdrawn
- 2011-07-08 WO PCT/US2011/043424 patent/WO2012006569A1/en not_active Ceased
-
2016
- 2016-05-18 US US15/158,005 patent/US10322159B2/en active Active
- 2016-07-08 JP JP2016136149A patent/JP2016172781A/ja active Pending
-
2018
- 2018-07-12 HK HK18109055.3A patent/HK1249428A1/zh unknown
-
2019
- 2019-01-04 JP JP2019000305A patent/JP2019052188A/ja active Pending
-
2020
- 2020-04-30 JP JP2020080135A patent/JP2020114880A/ja active Pending
-
2021
- 2021-11-08 JP JP2021181839A patent/JP2022012924A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016172781A5 (cg-RX-API-DMAC7.html) | ||
| JP2017165772A5 (cg-RX-API-DMAC7.html) | ||
| US10314684B2 (en) | Simultaneous rotating separator, irrigator microcatheter for thrombectomy | |
| JP2013516425A5 (cg-RX-API-DMAC7.html) | ||
| US10299824B2 (en) | Rotating separator, irrigator microcatheter for thrombectomy | |
| US11877752B2 (en) | Filterless aspiration, irrigating, macerating, rotating microcatheter and method of use | |
| WO2009055742A3 (en) | Delivery of active agents | |
| Baek et al. | Effective mechanical thrombectomy in a patient with hyperacute ischemic stroke associated with cardiac myxoma | |
| Ristalli et al. | Intravascular lithotripsy and Impella support to assist complex LM angioplasty | |
| Amemiya et al. | Usefulness of oral Xa inhibitor for management of ischemic stroke associated with thrombosis in the pulmonary vein stump after lung resection | |
| Zhao et al. | Percutaneous sclerotherapy of arteriovenous malformations of the face using fibrin glue combined with OK-432 and bleomycin after embolisation | |
| Fanelli et al. | Drug-coated Balloons in the Femoropopliteal Region: Dream or Reality? | |
| Jung et al. | Successful surgical treatment of a right atrial myxoma complicated by pulmonary embolism | |
| Cortese et al. | Combined, superselective pharmacological management of large coronary thrombus burden | |
| Falluji et al. | Contemporary management of infrapopliteal peripheral arterial disease | |
| Alkawi et al. | Advances in thrombolytics and mechanical devices for treatment of acute ischemic stroke | |
| Gupta et al. | Bilateral Catheter-Directed Thrombolysis for an Acute Bilateral Pulmonary Embolism Patient with Severe Right Ventricular Strain From Intensive Care Unit to Home on Postoperative Day 1 | |
| Hokimoto et al. | Initial and mid-term outcomes of pulse infusion thrombolysis using a unique pump system and stent placement for deep vein thrombosis | |
| US20200405332A1 (en) | Pharmaceutical compositions and methods for the treatment of thrombosis and delivery by medical devices | |
| Mistry et al. | Vascular Access Guidelines | |
| Dziewierz et al. | Local administration of abciximab using a ClearWay RX infusion catheter in a patient with acute coronary syndrome caused by late in− stent thrombosis | |
| Lee et al. | Successful catheter-directed thrombolysis of a massive pulmonary embolism in a patient after recent pneumonectomy | |
| Şentürk et al. | Successful treatment of saphenous venous graft thrombus by tirofiban infusion | |
| Gersh | Acute myocardial infarction. Results of the ASSENT-3 Trial | |
| AU2019292557A1 (en) | Pharmaceutical compositions and methods for the treatment of thrombosis and delivery by medical devices |